Winslow Capital Management, LLC Dexcom Inc Transaction History

Winslow Capital Management, LLC

  • $27.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$75.49 - $124.16 $37.1 Million - $61.1 Million
491,942 Added 26.51%
2,347,459 $291 Million
Q3 2023

Nov 13, 2023
BUY
$86.06 - $137.93 $160 Million - $256 Million
1,855,517 New
1,855,517 $173 Million
Q4 2017

Feb 12, 2018
SELL
$11.12 - $15.38 $9,018 - $12,473
-811 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$11.36 - $18.98 $9,212 - $15,392
811
811 $40,000

Others Institutions Holding DXCM

# of Institutions
1,014
Shares Held
351M
Call Options Held
5.51M
Put Options Held
5.6M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Winslow Capital Management, LLC Portfolio

Follow Winslow Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winslow Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Winslow Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email